These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

50 related articles for article (PubMed ID: 3627783)

  • 21. Left ventricular outflow tract gradient decrease with non-surgical myocardial reduction improves exercise capacity in patients with hypertrophic obstructive cardiomyopathy.
    Ruzyłło W; Chojnowska L; Demkow M; Witkowski A; Kuśmierczyk-Droszcz B; Piotrowski W; Rausinska L; Karcz M; Małecka L; Rydlewska-Sadowska W
    Eur Heart J; 2000 May; 21(9):770-7. PubMed ID: 10739733
    [TBL] [Abstract][Full Text] [Related]  

  • 22. [Myotomy-myomectomy as treatment of localized hypertrophic cardiomyopathy].
    Santibáñez Escobar F; Serrano Gallardo G; Ramírez Marroquín S; Zúñiga Monge JC; Herrera Alarcón V; Venegas Hermosillo F; Cisneros Tamayo E; Barragán García R
    Arch Inst Cardiol Mex; 1996; 66(1):55-9. PubMed ID: 8768623
    [TBL] [Abstract][Full Text] [Related]  

  • 23. [Evaluation of the effects of propranolol on hypertrophic cardiomyopathy by non-invasive technics].
    Fang WH; Hu ZX; Wang SH; Li JR; Liu YS
    Zhonghua Xin Xue Guan Bing Za Zhi; 1980 Mar; 8(1):13-5. PubMed ID: 7192621
    [No Abstract]   [Full Text] [Related]  

  • 24. Echocardiographic assessment of the effects of surgery and propranolol on the dynamics of outflow obstruction in hypertrophic subaortic stenosis.
    Shah PM; Gramiak R; Adelman AG; Wigle ED
    Circulation; 1972 Mar; 45(3):516-21. PubMed ID: 5062429
    [No Abstract]   [Full Text] [Related]  

  • 25. Muscular subaortic stenosis. Prevention of outflow obstruction with propranolol.
    Flamm MD; Harrison DC; Hancock EW
    Circulation; 1968 Nov; 38(5):846-58. PubMed ID: 4177137
    [No Abstract]   [Full Text] [Related]  

  • 26. [Alternations of cardiac performance in the avoluations of obstructive cardiomyopathy. Prognostic significance (author's transl)].
    Emeriau JP; Besse P; Sicart M; Conri C; Martin P; Bricaud H
    Ann Radiol (Paris); 1977; 20(3-4):371-8. PubMed ID: 560159
    [No Abstract]   [Full Text] [Related]  

  • 27. Septal motion in hypertrophic cardiomyopathy: its possible pathophysiological mechanism and histological manifestation in M- and real-time B-scan echocardiography.
    Gehrke J; Goodwin JF
    Basic Res Cardiol; 1979; 74(1):95-108. PubMed ID: 571274
    [No Abstract]   [Full Text] [Related]  

  • 28. [Echocardiography in hypertrophic cardiomyopathy in children].
    Ivanov AP; Khaĭdarov BM; Dvoriakovskaia GM; Serbin VI; Dvoriakovskiĭ IV
    Pediatriia; 1987; (3):59-62. PubMed ID: 3601541
    [No Abstract]   [Full Text] [Related]  

  • 29. Does outflow obstruction exist in hypertrophic cardiomyopathy?
    Murgo JP
    N Engl J Med; 1982 Oct; 307(16):1008-9. PubMed ID: 7202120
    [No Abstract]   [Full Text] [Related]  

  • 30. The Q waves of hypertrophic cardiomyopathy: an electrophysiologic study.
    Cosio FG; Moro C; Alonso M; de la Calzada CS; Liovet A
    N Engl J Med; 1980 Jan; 302(2):96-9. PubMed ID: 7188623
    [No Abstract]   [Full Text] [Related]  

  • 31. Hypertrophic obstructive cardiomyopathy prevention of outflow obstruction with propranolol.
    Vijayaraghavan G; Cherian G
    J Assoc Physicians India; 1976 Oct; 24(10):631-6. PubMed ID: 1035908
    [No Abstract]   [Full Text] [Related]  

  • 32. Hypertrophic cardiomyopathy--an overview.
    Kar CC; Kar S
    Indian Heart J; 1988; 40(2):72-5. PubMed ID: 3056850
    [No Abstract]   [Full Text] [Related]  

  • 33. [Proceedings: The mitral valve mobility in echocardiography in hypertrophic cardiomyopathy with obstruction and its modification following treatment with beta receptors].
    Rinke H; Späth M; Rudolph W
    Z Kardiol; 1975; Suppl 2():15. PubMed ID: 128231
    [No Abstract]   [Full Text] [Related]  

  • 34. [The respective roles of medical and of surgical treatment in obstructive cardiomyopathy (author's transl)].
    Perrin A
    Ann Radiol (Paris); 1977; 20(3-4):425-7. PubMed ID: 18080
    [No Abstract]   [Full Text] [Related]  

  • 35. The natural history of hypertrophic cardiomyopathy.
    McKenna WJ; Goodwin JF
    Curr Probl Cardiol; 1981 Jul; 6(4):1-26. PubMed ID: 7026177
    [No Abstract]   [Full Text] [Related]  

  • 36. Clinical course of patients with hypertrophic cardiomyopathy.
    Maron BJ; Epstein SE
    Cardiovasc Clin; 1979; 10(1):253-65. PubMed ID: 574058
    [No Abstract]   [Full Text] [Related]  

  • 37. Propranolol in management of muscular subaortic stenosis.
    Sloman G
    Br Heart J; 1967 Sep; 29(5):783-7. PubMed ID: 6068465
    [No Abstract]   [Full Text] [Related]  

  • 38. The course in idiopathic hypertrophic muscular subaortic stenosis.
    Parker BM
    Ann Intern Med; 1969 May; 70(5):903-11. PubMed ID: 5814097
    [No Abstract]   [Full Text] [Related]  

  • 39. Propranolol and arrhythmia in hypertrophic cardiomyopathy.
    Canedo MI; Frank MJ; Abdulla AM
    Am J Cardiol; 1980 Oct; 46(4):704-5. PubMed ID: 7191199
    [No Abstract]   [Full Text] [Related]  

  • 40. Letter: Surgical correction of ASH.
    Oakley CM
    Circulation; 1975 May; 51(5):951-3. PubMed ID: 1168104
    [No Abstract]   [Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 3.